Robyn Banerjee

Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)

Sue S. Yom, Pedro A. Torres‐Saavedra, Jimmy J. Caudell et al. · Journal of Clinical Oncology · 2021 · 374 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma

David A. Palma, Eitan Prisman, Eric Berthelet et al. · JAMA Oncology · 2022 · 102 citations · Full text

Medicine, Oncology, Radiation Oncology +10

NRG-HN002: A Randomized Phase II Trial for Patients With p16-Positive, Non-Smoking-Associated, Locoregionally Advanced Oropharyngeal Cancer

Sue S. Yom, Pedro A. Torres‐Saavedra, Jimmy J. Caudell et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 87 citations

Medicine, Oncology, Molecular Oncology +4

Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial

Anthony C. Nichols, Pencilla Lang, Eitan Prisman et al. · BMC Cancer · 2020 · 74 citations · Full text

Medicine, Oncology, Radiation Oncology +10

Small Bowel Dose Parameters Predicting Grade ≥3 Acute Toxicity in Rectal Cancer Patients Treated With Neoadjuvant Chemoradiation: An Independent Validation Study Comparing Peritoneal Space Versus Small Bowel Loop Contouring Techniques

Robyn Banerjee, Santam Chakraborty, Ian Nygren et al. · International Journal of Radiation Oncology*Biology*Physics · 2012 · 68 citations

Medicine, Oncology, Radiation Oncology +14